<?xml version="1.0" encoding="UTF-8"?>
<p>CLL can result in one or more of the following risk factors for infection: hypogammaglobulinemia, qualitative and quantitative B and T cell defects including impaired response to vaccination and CD4+ lymphopenia, innate immune dysfunction, and neutropenia among others.
 <sup>
  <xref rid="R11" ref-type="bibr">11</xref>
 </sup> These can be exacerbated by anti-leukemic treatments and are known risk factors for viral infections.
 <sup>
  <xref rid="R12" ref-type="bibr">12</xref>,
  <xref rid="R13" ref-type="bibr">13</xref>
 </sup> Thus, we can speculate that this existing immune suppression might also prevent or delay CLL patient's ability to react against the SARS-CoV-2 virus or to cope with COVID-19.
</p>
